Fojann Smart Medicine - Let precision medicine illuminate the future of human health

Fojann Biopharmaceuticals Limited is a leading global provider of in-vitro colonoscopy screening, intelligent gut microbiome solutions, and probiotics. With operations spanning the globe, Fojann has established offices in the United States, Australia, Japan, Malaysia, Hong Kong, and China, aiming to safeguard global human health.

Positioned at the forefront of microbiome and immunomodulation research, Fojann has built a "multi-omics big data + AI intelligent medicine" dual-core driven technology platform. This platform deeply integrates core technologies from bioinformatics, artificial intelligence, and clinical medicine. The company specializes in early in-vitro screening for Inflammatory Bowel Disease (IBD), microbial detection for precise immune system assessment, and effective interventions, providing global users with an end-to-end solution from risk warning to personalized health management.